ctrl K

Watchlist Price Alert

ZyVersa Therapeutics Inc. (ZVSA)

NASDAQ: ZVSA · Real-Time Price · USD

0.68

0.05 (7.59%)

At close: Jun 17, 2025, 10:47 AM

ZyVersa Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	10.4K	10.4K	10.4K	10.4K
Gross Profit	n/a	-10.4K	-10.4K	-10.4K	-10.4K
Operating Income	-9.14B	-14.42M	-13.01M	-7.7M	-11.83M
Interest Income	n/a	n/a	427.54	821.37	516.45
Pretax Income	-9.42B	-107.75M	-14.05M	-8.08M	-12.68M
Net Income	-9.41B	-98.3M	-759.1M	-8.91M	-13.2M
Selling & General & Admin	7.36B	11.2M	7.61M	5.58M	5.36M
Research & Development	1.78B	3.21M	5.41M	2.12M	6.47M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	9.13M	14.41M	13.01M	7.7M	11.83M
Interest Expense	269.86K	-457K	427.54K	821.37K	516.45K
Selling & Marketing Expenses	n/a	-11.2B	n/a	n/a	n/a
Cost & Expenses	n/a	14.42M	13.01M	7.7M	11.83M
Income Tax Expense	-6.75M	-9.46M	745.05M	821.37K	516.45K
Shares Outstanding (Basic)	11.1M	975.03K	259.48K	465.52K	465.52K
Shares Outstanding (Diluted)	11.1M	975.03K	259.48K	465.52K	465.52K
EPS (Basic)	-848.03	-1.09K	-930.25	-173.66	-272.45
EPS (Diluted)	-848.03	-1.09K	-930.25	-173.66	-272.45
EBITDA	-9.14B	-107.74M	-11.67M	-7.25M	-12.16M
EBIT	-9.15B	-107.75M	-14.44M	-7.26M	-12.17M
Depreciation & Amortization	n/a	10.4K	10.4K	10.4K	10.4K